Lin H, Li C, Zhang W, Wu B, Wang Y, Wang S
Int J Biol Sci. 2024; 20(8):2833-2859.
PMID: 38904025
PMC: 11186374.
DOI: 10.7150/ijbs.94346.
Nayak R, Orellana D
Immunol Rev. 2024; 325(1):107-130.
PMID: 38864582
PMC: 11338731.
DOI: 10.1111/imr.13358.
Ogawa A, Kawamoto H, Hara J, Kikuta A, Ogawa C, Hiraga H
Cancer Chemother Pharmacol. 2024; 94(1):89-101.
PMID: 38478074
PMC: 11258064.
DOI: 10.1007/s00280-024-04664-6.
Lee J, Corless B, Gardner T, Scheinberg D, Tan D
Org Lett. 2023; 25(34):6295-6299.
PMID: 37602700
PMC: 10543097.
DOI: 10.1021/acs.orglett.3c02130.
You Y, Doi Y, Maeda N, Masuo S, Takeshita N, Takaya N
BMC Microbiol. 2022; 22(1):225.
PMID: 36167524
PMC: 9513972.
DOI: 10.1186/s12866-022-02643-6.
Microbial cytosine deaminase is a programmable anticancer prodrug mediating enzyme: antibody, and gene directed enzyme prodrug therapy.
El-Sayed A, Mohamed N, Yassin M, Amer M, El-Sharkawy R, El-Sayed N
Heliyon. 2022; 8(9):e10660.
PMID: 36164544
PMC: 9508425.
DOI: 10.1016/j.heliyon.2022.e10660.
Engineering CAR-T cells to activate small-molecule drugs in situ.
Gardner T, Lee J, Bourne C, Wijewarnasuriya D, Kinarivala N, Kurtz K
Nat Chem Biol. 2021; 18(2):216-225.
PMID: 34969970
PMC: 9152922.
DOI: 10.1038/s41589-021-00932-1.
Biological Therapies in the Treatment of Cancer-Update and New Directions.
Papiez M, Krzysciak W
Int J Mol Sci. 2021; 22(21).
PMID: 34769123
PMC: 8583892.
DOI: 10.3390/ijms222111694.
Characterization of a Stable Form of Carboxypeptidase G2 (Glucarpidase), a Potential Biobetter Variant, From Acinetobacter sp. 263903-1.
Sadeghian I, Hemmati S
Mol Biotechnol. 2021; 63(12):1155-1168.
PMID: 34268672
DOI: 10.1007/s12033-021-00370-3.
studies on CNGRC-CPG2 fusion proteins for ligand-directed enzyme prodrug therapy for targeted cancer therapy.
Al-Mansoori L, Bashraheel S, Al Qahtani A, OConnor C, Elsinga P, Goda S
Oncotarget. 2020; 11(6):619-633.
PMID: 32110281
PMC: 7021235.
DOI: 10.18632/oncotarget.27478.
Isolation and molecular characterization of novel glucarpidases: Enzymes to improve the antibody directed enzyme pro-drug therapy for cancer treatment.
B Rashidi F, AlQhatani A, Bashraheel S, Shaabani S, Groves M, Domling A
PLoS One. 2018; 13(4):e0196254.
PMID: 29698433
PMC: 5919439.
DOI: 10.1371/journal.pone.0196254.
Consensus Guideline for Use of Glucarpidase in Patients with High-Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance.
Ramsey L, Balis F, OBrien M, Schmiegelow K, Pauley J, Bleyer A
Oncologist. 2017; 23(1):52-61.
PMID: 29079637
PMC: 5759822.
DOI: 10.1634/theoncologist.2017-0243.
Engineering carboxypeptidase G2 circular permutations for the design of an autoinhibited enzyme.
Yachnin B, Khare S
Protein Eng Des Sel. 2017; 30(4):321-331.
PMID: 28160000
PMC: 6283397.
DOI: 10.1093/protein/gzx005.
Comparison of Substrate Specificity of -Aminobenzoyl-Glutamate Hydrolase with Carboxypeptidase G.
Larimer C, Slavnic D, Pitstick L, Green J
Adv Enzyme Res. 2014; 2(1):39-48.
PMID: 27795973
PMC: 5082436.
DOI: 10.4236/aer.2014.21004.
Comprehensive identification of novel proteins and N-glycosylation sites in royal jelly.
Zhang L, Han B, Li R, Lu X, Nie A, Guo L
BMC Genomics. 2014; 15:135.
PMID: 24529077
PMC: 3942810.
DOI: 10.1186/1471-2164-15-135.
Glucarpidase to combat toxic levels of methotrexate in patients.
Green J
Ther Clin Risk Manag. 2012; 8:403-13.
PMID: 23209370
PMC: 3511185.
DOI: 10.2147/TCRM.S30135.
Crystal structure and mutational analysis of aminoacylhistidine dipeptidase from Vibrio alginolyticus reveal a new architecture of M20 metallopeptidases.
Chang C, Hsieh Y, Wang T, Chen Y, Wang Y, Chiang T
J Biol Chem. 2010; 285(50):39500-10.
PMID: 20819954
PMC: 2998127.
DOI: 10.1074/jbc.M110.139683.
Drugs and pharmaceuticals: management of intoxication and antidotes.
Smith S
EXS. 2010; 100:397-460.
PMID: 20358691
PMC: 7123602.
DOI: 10.1007/978-3-7643-8338-1_12.
Purification and characterization of the folate catabolic enzyme p-aminobenzoyl-glutamate hydrolase from Escherichia coli.
Green J, Hollandsworth R, Pitstick L, Carter E
J Bacteriol. 2010; 192(9):2407-13.
PMID: 20190044
PMC: 2863484.
DOI: 10.1128/JB.01362-09.
Functional overexpression and purification of a codon optimized synthetic glucarpidase (carboxypeptidase G2) in Escherichia coli.
Goda S, Rashidi F, Fakharo A, Al-Obaidli A
Protein J. 2009; 28(9-10):435-42.
PMID: 19911261
DOI: 10.1007/s10930-009-9211-2.